MREO Financials

Mereo Biopharma Group Plc - Financial statements & key metrics

Stock Price

$0.39

Market Cap

$62.71M

EPS

$-0.25

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-43.25M

EPS (Diluted)

$-0.06

Balance Sheet Highlights

Total Assets

$76.39M

Total Liabilities

$15.42M

Shareholders Equity

Cash & Equivalents

$69.80M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-32.83M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

73.4%

Operating Margin

-90.7%

ROE

-0.7%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is MREO revenue?

View MREO's income statement for detailed revenue data.

Is MREO profitable?

MREO reported a loss of $43.25M in the most recent quarter.

What is MREO market cap?

MREO has a market capitalization of $62.71M, making it a small-cap stock.

Does MREO have debt?

View MREO's balance sheet for debt information.

What is MREO cash flow?

Cash flow data is available in the full financial statements.